3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
16
OTHER_GOV
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Thoracic
2
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
89
Lung Neoplasms
78
Small Cell Lung Carcinoma
28
Adenocarcinoma of Lung
8
Mesothelioma, Malignant
6
Esophageal Neoplasms
6
Carcinoma, Hepatocellular
4
Adenocarcinoma
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
NSCLC
3
Motor Activity
3
Mesothelioma
3
Meningeal Carcinomatosis
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Thymoma
2
Sarcopenia
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms
2
Melanoma
2
Lung Diseases
2
EGFR Positive Non-small Cell Lung Cancer
2
Disease
2
Colorectal Neoplasms
2
Weight Loss
1
Untreated Advanced Non-small Cell Lung Cancer
1
Unresectable Non-small Cell Lung Cancer
1
Interventions
pembrolizumab
1
durvalumab
1
atezolizumab
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Sarcopenia
×
Thoracic
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled
NCT06796816
2025-01-28
BIVA-18
Azienda USL Reggio Emilia - IRCCS
Phase NA
Recruiting
1,000 enrolled